semaglutide aspiration GLP-1 receptor agonists like (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the perioperative setting. These Evaluating and managing semaglutide risk
Description
Additionally, Semaglutide has been demonstrated to significantly decrease appetite by delaying gastric emptying and reducing intestinal motility
The main benefit of using the drug long-term is maintaining weight loss or regulating blood sugar
In addition, hypothyroid patients may have co-existing relative adrenal insufficiency, thus weakening HPA response to hypoglycemia [145]
It has a specific pharmacological cause that sets retatrutide apart from every other approved or investigational GLP-1 medication including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)
Most changes are physiological responses to the metabolic improvements that GLP-1 produces and dont require intervention beyond observation
Probiotic GLP-1 supplements are dietary supplements, not medications
